Previous Article | Next Article 
Journal of Virology, June 2001, p. 5027-5035, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5027-5035.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Avian Reovirus Major µ-Class Outer Capsid Protein
Influences Efficiency of Productive Macrophage Infection in a Virus
Strain-Specific Manner
David
O'Hara,1
Megan
Patrick,2
Denisa
Cepica,1
Kevin M.
Coombs,2 and
Roy
Duncan1,*
Department of Microbiology and Immunology,
Dalhousie University, Halifax, Nova Scotia, Canada B3H
4H7,1 and Department of Medical
Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E
0W32
Received 28 September 2000/Accepted 7 March 2001
 |
ABSTRACT |
We determined that the highly pathogenic avian reovirus strain 176 (ARV-176) possesses an enhanced ability to establish productive infections in HD-11 avian macrophages compared to avian fibroblasts. Conversely, the weakly pathogenic strain ARV-138 shows no such macrophagotropic tendency. The macrophage infection capability of the
two viruses did not reflect differences in the ability to either induce
or inhibit nitric oxide production. Moderate increases in the ARV-138
multiplicity of infection resulted in a concomitant increase in
macrophage infection, and under such conditions the kinetics and extent
of the ARV-138 replication cycle were equivalent to those of the highly
infectious ARV-176 strain. These results indicated that both viruses
are apparently equally capable of replicating in an infected
macrophage, but they differ in the ability to establish productive
infections in these cells. Using a genetic reassortant approach, we
determined that the macrophagotropic property of ARV-176 reflects
a post-receptor-binding step in the virus replication cycle and that
the ARV-176 M2 genome segment is required for efficient infection of
HD-11 cells. The M2 genome segment encodes the major µ-class outer
capsid protein (µB) of the virus, which is involved in virus entry
and transcriptase activation, suggesting that a host-specific influence
on ARV entry and/or uncoating may affect the likelihood of the virus
establishing a productive infection in a macrophage cell.
 |
INTRODUCTION |
The avian reoviruses (ARV) differ
from the prototypical mammalian reoviruses (MRV) based on several
biological properties other than just their distinct host ranges.
Unlike MRV, ARV is naturally pathogenic in its avian host, lacks
hemagglutinating ability, and is one of the few nonenveloped viruses
capable of inducing syncytium formation in infected cell cultures and
in vivo (14, 18, 24, 28). Although ARV pathogenesis has
been extensively described (5, 6, 15, 34), the viral
factors that influence ARV-host cell interactions and pathogenesis
remain poorly understood.
We have been investigating two ARV strains that possess distinct
pathogenic and syncytium-inducing potentials. Previous results demonstrated that ARV-176 is highly pathogenic relative to ARV-138 in
an embryonated egg model of virus pathogenesis, an attribute that
correlates with the relative fusogenic capability of the virus
(8). Both viruses infect and replicate with equal
efficiency in cultured fibroblast cells, they display 94 to 98% amino
acid sequence identity in the three sequenced S-class genome
segment-encoded proteins (7a), and all 10 of their individual genome
segments can be resolved by electrophoretic analysis (8);
these properties make these two ARV strains ideal parental virus
candidates for genetic and molecular approaches to identify viral
determinants of host interaction and pathogenicity. We previously used
a genetic reassortant approach to reveal that the S1 genome segment of
ARV-176 is solely responsible for the syncytium-inducing property of
the virus (8). Subsequent molecular and biochemical
studies confirmed the role of the S1 genome segment and its encoded
10-kDa protein in cell fusion (30). Genetic studies also
revealed that while the S1 genome segment, and by inference syncytium
formation, makes a significant contribution to the pathogenic potential
of ARV, other genetically encoded viral properties also contribute to ARV-176 pathogenicity (8). Aside from the distinct
pathogenic and syncytium-inducing characteristics of these two ARV
strains, no other distinguishing viral attributes have been identified that could influence virus-host interactions.
Macrophages may be a preferred target cell population for ARV
replication (38), which could conceivably contribute to
the transient immunosuppression observed following ARV infection
(25). Furthermore, there is evidence suggesting virus
strain-specific differences in the ability of ARV to infect cultured
macrophages (23). However, the relationship between
macrophage infection and pathogenesis remains unclear (12,
38). These studies prompted us to evaluate ARV-176 and ARV-138
macrophage interactions using an avian macrophage cell line, HD-11.
ARV-176 was approximately 25-fold more efficient at establishing
productive infections in macrophage versus fibroblast cell cultures,
while ARV-138 showed no such macrophagotropic property. Genetic studies
indicated that the ARV-176 M2 genome segment, which encodes the major
µ-class outer capsid protein of the virus, is necessary for enhanced
macrophage infection. In view of the role of this outer capsid protein
in virus entry and transcriptase activation, differences in the
endosomal entry pathway between fibroblasts and macrophages could
contribute to the observed differences in ARV macrophage infection.
 |
MATERIALS AND METHODS |
Virus strains and cells.
ARV-176 and ARV-138 have been
previously described (8). Both strains were plaque
purified and amplified to passage 4 using a multiplicity of infection
of 0.01 in the continuous quail fibroblast cell line QM5. The QM5 cell
line has been previously described (8). HD-11 is a
continuous chicken macrophage cell line developed by transforming bone
marrow-adherent cells with the replication defective avian retrovirus
MC29 (1). The HD-11 cells were obtained from John Adams
(University of California, Los Angeles) and were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum and 1%
penicillin-streptomycin at 37°C.
Focus-forming assay.
The relative infectivities of ARV-176
and ARV-138 in QM5 fibroblasts and HD-11 macrophages were compared and
quantified using a focus-forming assay. Concentrated virus stocks were
obtained by differential centrifugation of infected QM5 cell lysates as previously described (9). Serial virus dilutions were used to infect QM5 and HD-11 cell monolayers, and the monolayers were fixed
with methanol at 9 to 16 h postinfection (hpi). Fixed monolayers were stained using polyclonal rabbit antiserum raised against virus
structural proteins and a secondary goat anti-rabbit immunoglobulin G
conjugated with alkaline phosphatase (Life Technologies) as reported
previously (9).
Quantification of infectious foci was achieved using the computer
software Image-Pro Plus (version 4.0). Duplicate stained cell
monolayers were observed by bright-field microscopy at a magnification
of ×100 using a Nikon Diaphot-TMD inverted microscope and were
photographed with a Sony DXC-950 color video camera. Five separate
fields per duplicate dilution were quantified. The experiment was
repeated at least three times for each virus. Captured images were
subjected to background spatial filtering set to bright at 100 pixels
to obtain an equal distribution of light intensity throughout each
image capture. To avoid counting objects smaller than individual cells
the minimum area filter range was set to 5 pixels. An 8-bit gray scale
was selected for quantification. The intensity range selection (0 to
255) was set on manual and to the level which identified the areas in
the cell monolayers stained with antireovirus antibodies. Twofold
dilutions were used to ensure a linear dose response between foci
counted and viral concentration. The relative infectivity was reported
as the HD-11/QM5 focus-forming ratio.
The reassortant viruses were similarly analyzed to determine their
relative infectivities. A one-way analysis of variance using Tukey's
pairwise comparisons was used to analyze the relative infectivities of
the parental and reassortant viruses and to assign the viruses to one
of three phenotypic groups. The family error rate (the probability that
there are not three distinct groups) had a P value of
<0.05, and the individual error rate (the probability that any given
virus is not in a specific group) had a P value of <0.0001.
The M2 genome segment was identified as a predictor of macrophage
infection efficiency using a generalized linear model to fit a
regression model predicting the log of the relative infectivity
(P < 0.001).
Progeny virus yield and viral protein synthesis.
To compare
the replication abilities per infected cell of ARV-176 and ARV-138 in
QM5 and HD-11 cells, monolayer cultures were infected with the minimum
dose of virus required for a >90% infection as determined by
immunostaining. After attachment for 1 h at 37°C, the inoculum was
removed and the monolayers were washed three times with warm
phosphate-buffered saline followed by the overlay of 1% fresh medium.
Duplicate wells containing infected monolayers were harvested at 24 or
48 hpi by scraping the cells into the culture medium, cells were
disrupted by three freeze-thaw cycles, and the total infectious progeny
virus titer was determined by plaque assay on QM5 cell monolayers as
previously described (9).
The kinetics and extent of viral protein synthesis in monolayers of
HD-11 and QM5 cells, infected as described above, were analyzed by
[35S]methionine pulse-labeling and sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as previously
described (9).
Greiss assay.
A standard assay was used to quantify the
levels of nitrite present in the culture medium as an indicator of the
relative inducible nitric oxide synthase (iNOS) activity
(11). To measure iNOS activity in infected or uninfected
HD-11 cells, monolayers were incubated in the absence or presence of
500 ng of lipolysaccharide (LPS) per ml for 6 h. Cells were then
either mock infected or infected with equivalent QM5 focus-forming
units of ARV-176 or ARV-138 under conditions that gave a >90%
infection by ARV-176. The monolayers were incubated with 500 µl of
phenol red-free RPMI 1640 at 37°C for 12 to 16 h. Following
incubation, 100 µl of Greiss reagent, composed of a 1:1 mixture of
1% sulfanilamide in 2.5% phosphoric acid and 0.1% naphthylenediamine
dihydrochloride in 2.5% phosphoric acid, was added to 100 µl of
sample supernatants and the absorbance at 550 nm was measured. To
determine the concentration of nitrite production from HD-11 cells, a
sodium nitrite standard curve with a range of 500 to 0.5 µM was
created using a 5 mM sodium nitrite stock solution diluted in phenol
red-free RPMI 1640.
Isolation of ARV reassortants.
ARV reassortants were
generated by slight modifications of standard techniques used to make
MRV reassortants (13). Briefly, subconfluent monolayers of
QM5 cells in 24-well tissue culture plates were infected with a mixture
of ARV-138 and ARV-176, at multiplicities of infection of 5:5, 12:3,
and 3:12 PFU per cell per clone. Infected cells were incubated at
37°C for 24 h (approximately one round of replication),
freeze-thawed twice, and disrupted with an ultrasonic sonicator to
dissociate clumps. Serial dilutions of viral lysates were prepared and
plated under medium 199-1% agar as described previously
(9). Individual plaques representing putative reassortants
separated by at least 1 cm were picked and amplified through two passages.
RNA analysis.
Each of the twice-passaged putative
reassortant stock clones was used to infect subconfluent QM5 monolayers
in P100 dishes. Cytoplasmic extracts were prepared from each infection
as described previously (13). Briefly, cells were
harvested when they showed a >50% cytopathic effect, nuclei were
removed, and double-stranded RNA was phenol-chloroform extracted from
the cytoplasmic fractions. RNA was precipitated with ethanol, dried,
and resuspended in electrophoresis sample buffer (0.24 M Tris [pH
6.8], 1.5% dithiothreitol, 1% SDS). Samples were heated to 65°C
and resolved by SDS-PAGE (16.0 by 16.0 by 0.1 cm gel) under standard
Laemmli conditions (typical conditions were 12.5% acrylamide gels
electrophoresed at 12 mA for 68 h). All reassortants were analyzed
on multiple gels and under different electrophoretic conditions (7, 10, and 12.5% acrylamide gels, altered times of electrophoresis) to obtain
maximal resolution of the individual L-, M-, and S-class genome
segments. Gels were then stained with ethidium bromide, and RNA was
visualized on a UV light box and photographed with Polaroid film.
Alternatively, images were captured with a Bio-Rad Gel Doc 2000 system
and manipulated with Adobe Photoshop.
 |
RESULTS |
Strain-specific differences in ARV infection of HD-11 macrophage
cultures.
The HD-11 myelomonocytic cell line is a chicken bone
marrow-derived cell line obtained by transformation with the
replication-defective avian retrovirus MC29 (1). This cell
line displays many macrophage-like properties, including high
phagocytic capability and expression of Fc receptors, secretion of
interleukin-1B, macrophage inflammatory protein 1
, interleukin-8,
and tumor necrosis factor alpha (TNF-
), and iNOS activity following
stimulation with TNF-
and/or LPS (1, 31, 33, 39, 40).
We used the HD-11 cell line as a model system to assess ARV-176 and
ARV-138 macrophage interactions using a focus-forming assay.
Both viruses were first standardized using the focus-forming assay in
the permissive QM5 quail fibroblast cell line. QM5 monolayers were
infected with serial dilutions of ARV-176 or ARV-138 virus stocks, and
monolayers were fixed and immunostained at 16 hpi using ARV-specific
antiserum (Fig. 1). Previous results
indicated that this time point is prior to the release of progeny virus particles (9); therefore, the antigen-positive foci
represent the primary foci of infection. As previously reported
(8) and as shown in Fig. 1a and b, ARV-176 is more
fusogenic than ARV-138, resulting in larger, though in equivalent
numbers, syncytial foci of infection in the infected QM5 monolayers.

View larger version (164K):
[in this window]
[in a new window]
|
FIG. 1.
ARV-176 shows a predilection for macrophages. Diluted
stocks of ARV-138 and ARV-176 were used to infect QM5 fibroblasts (a
and b, respectively). Infected cell monolayers were incubated at 37°C
and fixed at 16 hpi before being immunostained using a
reovirus-specific rabbit polyclonal antiserum and goat anti-rabbit
immunoglobulin G conjugated with alkaline phosphatase to detect viral
foci of infection. Virus dilutions that gave equivalent numbers of foci
in QM5 fibroblasts were then used to infect HD-11 macrophages (c and d)
that were similarly fixed and immunostained at 9 hpi.
|
|
Infection of HD-11 macrophages using virus stocks diluted to give
equivalent QM5 focus-forming units/ml gave very different results.
While equivalent aliquots of ARV-138 gave approximately equal numbers
of infectious foci in both QM5 and HD-11 cells (Fig. 1a and c), ARV-176
displayed a dramatic increase in the number of foci established in the
HD-11 cells (Fig. 1d). For presentation purposes, the HD-11 cells were
fixed and stained at 9 hpi to minimize the overlap of individual foci
due to syncytium formation. Extended incubation to 16 hpi before
fixation did not contribute to an increase in the numbers of foci
observed with ARV-138 (data not shown). The relative infectivities of
the two viruses in QM5 and HD-11 cells were quantified using the
focus-forming assay and serial virus dilutions, as described in
Materials and Methods (Fig. 2). In
repeated experiments, the relative infectivity of ARV-138 in HD-11
versus QM5 cells ranged from 0.8 to 1.2. Conversely, ARV-176 displayed
a consistent and reproducible HD-11/QM5 relative infectivity ratio of
25 to 30:1. These results clearly indicated that ARV-176 preferentially
establishes productive infections in macrophage cell cultures.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Relative infectivities of ARV-176 and ARV-138 in
macrophages versus fibroblasts. Both viruses were serially diluted and
used to infect monolayers of QM5 fibroblasts (gray bars). Virus
dilutions that gave equivalent numbers of foci of infection in QM5
cells were similarly used to infect HD-11 macrophages (black bars).
Infected monolayers were immunostained to detect viral foci of
infection as described for Fig. 1. The average number of foci of
infection per field at a magnification of ×100 was determined after
correcting for the relative virus dilution, as described in Materials
and Methods. Results are presented as means and standard errors from a
representative experiment.
|
|
ARV-176 and ARV-138 do not differentially stimulate or inhibit NO
production.
Nitric oxide (NO) is a reactive nitrogen species
produced by iNOS in macrophages activated by TNF-
and/or LPS. NO is
a potential potent inhibitor of the replication of numerous viruses,
including ARV replication in HD-11 cells (25, 26). Studies
have also shown strain-specific differences in the ability of avian
influenza viruses to inhibit NO production in HD-11 cells, a property
that correlated with virus virulence and viral replication
(21). It therefore seemed plausible that the observed
difference in the ability of ARV-176 and ARV-138 to establish
productive infections in HD-11 macrophages might reflect a
strain-specific difference in the activation or inhibition of iNOS activity.
To test this hypothesis, we examined iNOS activity in ARV-infected
HD-11 cells by measuring the accumulation of sodium nitrite, the stable
end product of NO reduction, in the culture medium. Uninfected or
ARV-infected HD-11 cell monolayers all showed equivalent low basal
levels of sodium nitrite in the culture medium, indicating that neither
virus stimulates NO production (Fig. 3).
We also examined whether either virus could inhibit NO production in
activated HD-11 cells. Incubation of HD-11 cells in the presence of LPS stimulated iNOS activity, as indicated by the high levels of sodium nitrite detected in culture supernatants at 12 h posttreatment (Fig. 3)
and as previously reported (33). Neither virus was capable
of inhibiting NO production by activated macrophages (Fig. 3), and the
replication of both viruses was equally impaired by LPS treatment (data
not shown), as previously reported for ARV-176 (26).
Therefore, the differential ability of these two ARV strains to
establish productive infections in HD-11 macrophages is not related to
NO production and/or inhibition.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Neither ARV-176 nor ARV-138 differentially affects NO
production by infected macrophages. HD-11 cell monolayers were
incubated for 6 h in the presence (black bars) or absence (gray
bars) of LPS at 500 ng/ml followed by infection with equivalent
concentrations of QM5 focus-forming units of ARV-176 or ARV-138 per
milliliter. At 12 hpi the supernatants were harvested and assayed for
the presence of nitrite using standard protocols. Nitrite
concentrations were determined relative to a standard sodium nitrite
curve. Uninf., uninfected cells.
|
|
Characterization of ARV infection and replication in HD-11
macrophages.
One mechanism that might account for the differences
in virus infectivity observed in the two cell types is that the HD-11 macrophage line consists of a mixed population of cells, some of which
are exclusively susceptible to infection by ARV-176. Such a situation
has been reported in other virus systems where, for example, the stage
of macrophage differentiation or the expression of cell surface
receptors on a subpopulation of macrophages dictates the outcome of
virus infection (4, 20, 35). To test this hypothesis,
HD-11 cells were infected with various amounts of ARV-138. Stepwise
twofold increases in the QM5-standardized ARV-138 inoculum resulted in
concomitant stepwise increases in the number of foci of infection in
both the QM5 and HD-11 cells. Essentially complete infection by ARV-138
of the HD-11 cell monolayer was achieved by a 16- to 32-fold increase
in the concentration of the standardized inoculum (Fig.
4). Clearly, both ARV-138 and ARV-176 are
capable of establishing productive infections in all of the cells
present in an HD-11 cell monolayer, suggesting that there is no
distinct subpopulation of HD-11 cells that is specifically permissive
for ARV-176 infection. Rather, the balance between host cell defenses
and virus infection appears to be tipped more in favor of the virus in
the case of ARV-176 such that this strain of ARV is more efficient at
establishing a productive infection in any given macrophage cell.

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 4.
ARV-138 is capable of complete infection of HD-11
macrophage monolayers. HD-11 macrophages were left uninfected (b) or
were infected with increasing concentrations of standardized QM5
focus-forming units of ARV-176 (a) or ARV-138 (c) per milliliter.
Monolayers were fixed and immunostained as described for Fig. 1 to
reveal viral foci of infection. The ARV-138 inoculum in panel c
corresponds to a 32-fold increase in the QM5 focus-forming units
compared to the ARV-176 inoculum in panel a.
|
|
The immunostaining protocol used in the focus-forming assay indicated
that both viruses could establish equivalent productive infections in
macrophage cells, at least to the point where robust virus translation
occurs. It was not clear, however, whether both viruses were equally
capable of completing their replication cycle within a particular
infected macrophage. To more clearly assess the kinetics and extent of
the virus replication cycle within an infected cell, virus translation
and progeny virus production were evaluated in QM5 and HD-11 cell
cultures infected with the minimum virus inoculum required for complete
infection of the monolayer, as indicated in Fig.
4. The results indicated that under these
infection conditions, there were no obvious differences in either the
rate or extent of virus translation or progeny virus production when
comparing the various virus-cell combinations (Fig.
5). The kinetics and extent of virus
translation were equivalent when comparing either one virus to the
other or one particular virus in either cell line with predominant
viral proteins evident at 12 hpi and diminishing by 16 hpi (Fig. 5A).
The same situation applied when cells were examined at 4 hpi (data not
shown). Similar to the results observed with virus translation, neither
virus showed preferential progeny virus production in a particular cell type under infection conditions sufficient to infect the majority of
cells in the monolayer (Fig. 5B). The previously reported enhanced replicative ability of ARV-138 versus ARV-176 in quail fibroblasts (8) was conserved in HD-11 cells; ARV-138 progeny titers
were approximately threefold higher than those of ARV-176 (Fig. 5B). These results indicated that ARV-176 possesses an enhanced ability to
establish a productive infection in any given macrophage cell but not
an enhanced ability to replicate within a productively infected cell.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 5.
ARV-176 and ARV-138 protein synthesis and replication
are similar in fibroblasts and macrophages. (A) Cell monolayers of
quail QM5 fibroblasts or HD-11 macrophages were left uninfected (U) or
infected with ARV-176 (176) or ARV-138 (138) using the minimum
concentrations of virus inocula required for complete infection of the
monolayer (see Fig. 4). Cultures were pulse-labeled for 1 h with
[35S]methionine at 12 and 16 hpi, and the radiolabeled
cell lysates were fractioned by SDS-PAGE and detected by
autoradiography. The locations of the major , µ, and classes
of viral proteins are indicated on the right. (B) Monolayers of quail
QM5 fibroblasts or HD-11 macrophage cells were infected with ARV-176
(gray bars) or ARV-138 (black bars) as described for panel A. Infected
cultures were harvested at 48 hpi, and the yield of infectious progeny
virions was determined by a plaque assay on QM5 cell monolayers.
Results are presented as means and standard errors from a
representative experiment.
|
|
Reassortant analysis implicates the ARV-176 M2 genome segment in
HD-11 infectivity.
We undertook a genetic approach to identify the
viral factors involved in the distinct macrophagotropic properties of
ARV-138 and ARV-176. A panel of 29 reassortant viruses was isolated
following coinfection of QM5 cells by the two virus strains. A select
panel of the reassortant genomes is shown in Fig.
6. The assignment of genome segments to a
particular parental virus was accomplished by repeated analysis under
different electrophoretic conditions designed to specifically resolve
individual L-, M-, and S-class genome segments (see Materials and
Methods). Viral stocks were prepared from each of the reassortants, and
their infectivities were standardized using the QM5 focus-forming assay
as described above. Serial dilutions of the standardized inocula were
then used to infect HD-11 cell monolayers, and the relative
focus-forming propensity of each clone in both cell types was
determined (Fig. 7).

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 6.
Genome segment profiles of parental and reassortant ARV
virions. Viral double-stranded RNA was isolated from concentrated virus
stocks of the parental and reassortant viruses, and individual genome
segments were resolved on SDS-12.5% PAGE gels. Gels were stained with
ethidium bromide and visualized under UV illumination. Images were
captured and enhanced with Adobe Photoshop, and negative images were
printed. The parental ARV-176 and ARV-138 genome segment profiles are
shown by themselves in the left-hand panel and included as markers on
the gels that contain the reassortant genomes. Only a selected number
of reassortants used in this study are shown.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 7.
Genome segment assignments and relative infectivities of
ARV reassortants. Parental (black bars) and reassortant (gray bars)
clones are identified at the extreme left. For each reassortant, the
parental identity of each genome segment, as determined by its relative
mobility by SDS-PAGE, is indicated (3 for ARV-138 and 7 for ARV-176).
Reassortant virus stocks were standardized to give equal and countable
numbers of focus-forming units in quail QM5 fibroblasts. The
standardized inocula were then used to infect QM5 or HD-11 cell
monolayers. The infected QM5 and HD-11 cell monolayers were fixed and
immunostained, and the average number of foci per field was determined
as described for Fig. 2. The relative infectivity was calculated as the
ratio of HD-11/QM5 foci, and values were normalized to the relative
infectivity of ARV-138 arbitrarily set to a value of 1. Results are
presented as means and standard errors from three or more separate
experiments.
|
|
With the two parental viruses included with the reassortants, the
viruses visually and statistically (P < 0.05)
segregated into three separate groups based on their macrophage
infection propensities. The group with the highest relative infectivity contains ARV-176 alone, with an HD-11/QM5 average relative infectivity of 25. The second group contains five reassortants whose average relative infectivities ranged from approximately 6 to 9. This group
contains all of the viruses that possess the ARV-176 M2 genome segment.
The third group contains the remaining 24 reassortants, none of which
contain the ARV-176 M2 genome segment and all of which segregate with
ARV-138. The average relative infectivities of this last group range
from approximately 0.3 to 2. Most of the variability in the relative
infectivities of the last group reflected minor inherent variations in
the assay, as evidenced by the relative infectivities obtained for two
separate reassortants with identical genome segment profiles (R459 and
R103 have relative infectivities of 0.7 and 1.9, respectively). The
most notable reassortant in the ARV-138 group was R402, a
monoreassortant containing the ARV-138 M2 genome segment in an
otherwise ARV-176 genetic background (Fig. 6). R402 had a relative
infectivity of approximately 0.6 and was indistinguishable from ARV-138
when examined by the focus-forming assay (Fig.
8). These genetic studies clearly
indicated that the ARV-176 M2 genome segment is necessary for efficient macrophage infection (P < 0.001).

View larger version (159K):
[in this window]
[in a new window]
|
FIG. 8.
The ARV-176 M2 genome segment is required for enhanced
macrophage infection. Virus stocks of ARV-176 (a and b), ARV-138 (c and
d), and the ARV-138 M2 monoreassortant R402 (e and f) were standardized
to give equivalent concentrations of focus-forming units in quail QM5
fibroblasts (a, c, and e). The same virus dilutions were used to infect
HD-11 macrophage monolayers (b, d, and f). Cells were immunostained as
described for Fig. 1 to reveal viral foci of infection.
|
|
It was also apparent that additional virus genes or gene constellations
exert an auxiliary influence on macrophage infection, since none of the
ARV-176 M2-containing reassortants displayed the full infectivity of
the parental ARV-176 virus (Fig. 7). The asymmetry in the distribution
of the ARV-176 M2 genome segment among the panel of reassortants
precluded any meaningful statistical analysis to identify potential
second gene effects. However, the R509 monoreassortant (ARV-176 with an
ARV-138 M3 genome segment) suggests that the M3 genome segment likely
makes at least a minor (approximately twofold) contribution to the
enhanced ability of ARV-176 to infect macrophages. The remaining
ARV-176 M2 reassortants all contain the ARV-138 S2 and S3 genome
segments, suggesting the possibility that either or both of these
genome segments might also impact ARV infection of macrophages
(approximately two- to threefold). Therefore, while it is clear from
the present analysis that the ARV-176 M2 genome segment is required for
efficient macrophage infection, the M2 genome segment alone is not
sufficient for conferring the complete macrophagotropic property of
ARV-176, indicating that second gene effects modulate ARV macrophage infection.
 |
DISCUSSION |
Our current results revealed that there are clear virus
strain-specific differences in the tropism of ARV for HD-11
macrophages. We also demonstrated that this differential tropism does
not reflect differences in the iNOS pathway, that the two viruses
differ in the ability to establish a productive infection in
macrophages but not in the ability to replicate within an infected
macrophage, and that the M2 genome segment of ARV-176 is required for
the efficient establishment of a productive infection in HD-11 macrophages.
The distinct macrophagotropic properties of ARV-176 and ARV-138
represent the third defined difference in the attributes of these
viruses, the others being the extent of syncytium formation and embryo
pathogenesis. We have previously shown that the S1 genome segment,
which encodes the p10 fusion protein of ARV, contributes approximately
60% of the embryo pathogenic potential of ARV-176 (8). In
view of the ability of various strains of ARV to infect macrophages in
vivo and under culture conditions (12, 19, 23, 38), the
transient immunosuppression that accompanies ARV-176 infection
(25), and the central role of the macrophage in
orchestrating the early immune response to virus infection, it is
conceivable that the preferential infection of macrophages by ARV-176
in vivo could partially contribute to the S1 genome segment-independent
events that influence ARV pathogenesis. However, this would need to be
directly evaluated in vivo, since the macrophage infection propensity
of ARV-176 has never been evaluated in infected animals and the
relationship between ARV macrophage infection and virus pathogenicity
remains unclear (12, 38). Similar confusion regarding the
correlation between virus pathogenicity and macrophage infection exists
with other viruses, such as herpes simplex virus (10, 17).
A panel of ARV reassortants derived from two viruses with defined
quantitative differences in their pathogenicity and macrophage
infection independent of their relative replicative ability affords an
opportunity to more precisely define the role, if any, of macrophage
infection in ARV pathogenesis using animal or embryo models.
Aside from the possible implications for ARV pathogenesis, our present
results have also revealed several interesting features of
ARV-macrophage interactions and identified a virus gene that influences
these interactions. Macrophage activation and NO production in response
to virus infection can profoundly influence the outcome of
virus-macrophage interactions in other virus systems (27). However, such events do not appear to contribute to the ability of
different ARV strains to productively infect HD-11 macrophages. Neither
ARV-176 nor ARV-138 stimulated iNOS activity following HD-11 infection,
and both strains were equally susceptible to the antiviral effects of
NO produced by LPS-activated HD-11 cells (Fig. 3). We have not as yet
examined other cellular factors that may contribute to the differences
in the relative infectivities of these two ARV strains, although our
reassortant analysis suggests some potential candidates (see below).
The differential macrophage infection property of these two ARV strains
is a dose-dependent phenomenon and is easily overcome by modest
increases in the ARV-138 inoculum (Fig. 4). This suggests that there is
not a subpopulation of HD-11 cells exclusively susceptible to ARV-176
infection, as occurs, for example, with herpesviruses or Theiler's
virus, where the efficiency of macrophage infection reflects the state
of macrophage activation or differentiation (4, 16, 35).
Moreover, the analysis of virus translation and replication under
infection conditions that result in the productive infection of the
majority of the cells in a monolayer indicated that both viruses
replicate equally well within an infected fibroblast or macrophage. In
fact, the less infectious ARV-138 strain actually replicates to
slightly higher titers in either cell line once the barrier to
productive infection is overcome by moderate increases in the inoculum
concentration (Fig. 5). Apparently, the viruses differ only in the
ability to establish a productive infection in macrophage cells and not
in the ability to replicate within any given infected cell. It seems
reasonable to speculate that one or more of the steps in the ARV-176
replication cycle are enhanced in HD-11 cells relative to QM5
fibroblasts such that the likelihood of the virus establishing a
productive infection in a macrophage cell is increased.
Our genetic studies provided evidence that a postattachment step of the
ARV-176 replication cycle contributes to enhanced macrophage infection,
since the S1 genome segment did not correlate with the propensity for
macrophage infection. In addition to encoding the p10 fusion protein
(30), the S1 genome segment also encodes the
C cell
attachment protein of ARV (22, 29). Since the parental
source of the S1 genome segment was randomly distributed amongst the
reassortant viruses (Fig. 7), it is unlikely that the differential
macrophage infection property of these two strains of ARV reflects a
receptor-binding phenomenon. We have recently confirmed that both
viruses attach to HD-11 cells with equal efficiencies (D. O'Hara and
R. Duncan, unpublished data). Consequently, there is a host-specific
influence on some postattachment stage of the ARV replication cycle.
The genetic implication of the M2 genome segment in the enhanced
infection of HD-11 cells by ARV-176 suggests a possible enhanced entry
or uncoating step in the virus replication cycle. The M2 genome segment
encodes the µB major outer capsid protein of ARV (37),
the homolog of the MRV µ1 capsid protein. Cleavage and subsequent
removal of the µ-class outer capsid protein is associated with the
endosomal membrane interactions and conformational changes in the
capsid required for delivery of the transcriptionally active core
particle to the cytoplasm (2, 32, 36). As with MRV, ARV
entry is also a low-pH-dependent event that is accompanied by specific
cleavage of the major µ-class outer capsid protein (7).
Consequently, differences between ARV-138 and ARV-176 in the rate of
cleavage of the M2-encoded µB protein, in its membrane interaction
properties, or in the subsequent capsid rearrangements required for
activation of the core-associated transcriptase activity (3) could lead to altered delivery of the
transcriptionally active core particle to the cytoplasm of macrophages.
In addition to identifying a virus strain-specific difference in a
postattachment step of the ARV replication cycle in macrophage cells,
there is also a clear host-dependent effect on this same postattachment
step. It is conceivable that differences in the environment of the
endosome-lysosome compartment of macrophages versus fibroblasts could
contribute to altered processing of the ARV-176 outer capsid and virus
entry or uncoating. We are currently pursuing a molecular analysis of
the ARV µB protein and a biochemical analysis of the early stages of
the virus replication cycle in HD-11 cells in order to specifically
identify the nature of the host-specific effect on ARV macrophage
infection. Entry studies monitoring the rate and extent of parental and
reassortant virus µB cleavage in conjunction with sequence analysis
of the M2 genome segments should serve to clearly determine whether the
µB protein influences steps in the virus entry pathway that
contribute to virus-and cell-specific differences in ARV tissue tropism.
 |
ACKNOWLEDGMENTS |
We thank Jingyun Shou for technical assistance, Leonard MacLean
for assistance with statistical analysis, and Maya Shmulevitz for
insightful discussions.
This research was supported by grants from the Medical Research Council
of Canada to R.D. and to K.M.C. Studentship support from the Natural
Sciences and Engineering Research Council of Canada (to D.O.) and from
the Manitoba Health Research Council (to M.P.) is gratefully acknowledged.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Tupper Medical Building, Dalhousie
University, Halifax, Nova Scotia, Canada B3H 4H7. Phone: (902)
494-6770. Fax: (902) 494-5125. E-mail:
roy.duncan{at}dal.ca.
 |
REFERENCES |
| 1.
|
Beug, H.,
A. von Kirchbach,
G. Doderlein,
J. F. Conscience, and T. Graf.
1979.
Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation.
Cell
18:375-390[CrossRef][Medline].
|
| 2.
|
Borsa, J.,
M. D. Sargent,
C. M. Kay, and K. Oikawa.
1976.
Circular dichroism of intermediate particles of reovirus: elucidation of the mechanism underlying the specific monovalent cation effects on uncoating.
Biochim. Biophys. Acta
451:619-627[Medline].
|
| 3.
|
Borsa, J.,
M. D. Sargent,
P. A. Lievaart, and T. P. Copps.
1981.
Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process.
Virology
111:191-200[CrossRef][Medline].
|
| 4.
|
Bruun, T.,
A. K. Kristoffersen,
H. Rollag, and M. Gegre.
1998.
Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells.
APMIS
106:305-314[Medline].
|
| 5.
|
Clark, F. D.,
Y. Ni,
E. W. Collisson, and M. C. Kemp.
1990.
Characterization of avian reovirus strain-specific polymorphisms.
Avian Dis.
34:304-314[CrossRef][Medline].
|
| 6.
|
Drastini, Y.,
P. K. McKenna,
F. S. B. Kibenge, and A. Lopez.
1994.
Chymotrypsin and trypsin sensitivities of avian reoviruses.
Can. J. Vet. Res.
58:75-78[Medline].
|
| 7.
|
Duncan, R.
1996.
The low pH-dependent entry of avian reovirus is accompanied by two specific cleavages of the major outer capsid protein µ2C.
Virology
219:179-189[CrossRef].
|
| 7a.
|
Duncan, R.
1999.
Extensive sequence divergence and phylogenetic relationships between the fusogenic and nonfusogenic orthoreoviruses: a species proposal.
Virology
260:316-328[CrossRef][Medline].
|
| 8.
|
Duncan, R., and K. Sullivan.
1998.
Characterization of two avian reoviruses that exhibit strain-specific quantitative differences in their syncytium-inducing and pathogenic capabilities.
Virology
250:263-272[CrossRef][Medline].
|
| 9.
|
Duncan, R.,
Z. Chen,
S. Walsh, and S. Wu.
1996.
Avian reovirus-induced syncytium formation is independent of infectious progeny virus production and enhances the rate, but is not essential, for virus-induced cytopathology and virus egress.
Virology
224:453-464[CrossRef][Medline].
|
| 10.
|
Gortz, J.,
B. Brake,
V. Harle-Grupp, and D. Falke.
1991.
Replication of HSV-1 in murine peritoneal macrophages: comparison of various virus strains with different properties.
Arch. Virol.
79:173-187.
|
| 11.
|
Green, L.,
D. Wagner,
J. Glogowski,
P. Skipper,
J. Wishnok, and S. Tannenbaum.
1982.
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
Anal. Biochem.
126:131-138[CrossRef][Medline].
|
| 12.
|
Haffer, K.
1984.
In vitro and in vivo studies with an avian reovirus derived from a temperature-sensitive mutant clone.
Avian Dis.
28:669-676[CrossRef][Medline].
|
| 13.
|
Hazelton, P. R., and K. M. Coombs.
1995.
The reovirus mutant tsA279 has temperature-sensitive lesions in the M2 and L2 genes: the M2 gene is associated with decreased viral protein production and blockade in transmembrane transport.
Virology
207:46-58[CrossRef][Medline].
|
| 14.
|
Hieronymus, D. R. K.,
P. Villegas, and S. H. Kleven.
1983.
Identification and serological differentiation of several reovirus strains isolated from chickens with suspected malabsorption syndrome.
Avian Dis.
27:246-254[CrossRef][Medline].
|
| 15.
|
Hieronymus, D. R. K.,
P. Villegas, and S. H. Kleven.
1983.
Characteristics and pathogenicity of two avian reoviruses isolated from chickens with leg problems.
Avian Dis.
27:255-259[CrossRef][Medline].
|
| 16.
|
Jelachich, M. L.,
P. Bandyopadhyay,
K. Blum, and H. L. Lipton.
1995.
Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation.
Virology
209:437-444[CrossRef][Medline].
|
| 17.
|
Jiang, Y. M.,
T. Daikoku,
M. Yamamoto,
T. Morishima, and Y. Nishiyama.
1995.
Growth and cytopathogenicity of herpes simplex virus in a macrophage cell line, RAW264: a good indicator of intraperitoneal pathogenicity.
Microbiol. Immunol.
39:905-909[Medline].
|
| 18.
|
Kibenge, F. S. B.,
R. C. Jones, and C. E. Savage.
1985.
Effects of experimental immunosuppression on reovirus-induced tenosynovitis in light-hybrid chickens.
Avian Pathol.
16:73-92.
|
| 19.
|
Kibenge, F. S. B.,
G. E. Gwaze,
R. C. Jones,
A. F. Chapman, and C. E. Savage.
1985.
Experimental reovirus infection in chickens: observations on early viraemia and virus distribution in bone marrow, liver, and enteric tissues.
Avian Pathol.
14:87-98.
|
| 20.
|
Kowalchyk, K., and P. G. Plagemann.
1985.
Cell surface receptors for lactate dehydrogenase-elevating virus on subpopulation of macrophages.
Virus Res.
2:211-229[CrossRef][Medline].
|
| 21.
|
Lyon, J. A., and V. S. Hinshaw.
1993.
Inhibition of nitric oxide induction from avian macrophage cell lines by influenza virus.
Avian Dis.
37:868-873[CrossRef][Medline].
|
| 22.
|
Martinez-Costas, J.,
A. Grande,
R. Varela,
C. García-Martínez, and J. Benavente.
1997.
Protein architecture of avian reovirus S1133 and identification of the cell attachment protein.
J. Virol.
71:59-64[Abstract].
|
| 23.
|
Mills, J. N., and G. E. Wilcox.
1993.
Replication of four antigenic types of avian reovirus in subpopulations of chicken leukocytes.
Avian Pathol.
22:353-361[Medline].
|
| 24.
|
Nibert, M. L.,
L. A. Schiff, and B. N. Fields.
1996.
Reoviruses and their replication, p. 1557-1623.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Press, Philadelphia, Pa.
|
| 25.
|
Pertile, T. L.,
J. M. Sharma, and M. M. Walser.
1995.
Reovirus infection in chickens primes splenic adherent macrophages to produce nitric oxide in response to T cell-produced factors.
Cell. Immunol.
164:207-216[CrossRef][Medline].
|
| 26.
|
Pertile, T. L.,
K. Karaca,
J. M. Sharma, and M. M. Walser.
1996.
An antiviral effect of nitric oxide: inhibition of reovirus replication.
Avian Dis.
40:342-348[CrossRef][Medline].
|
| 27.
|
Reiss, C. S., and T. Komatsu.
1998.
Does nitric oxide play a critical role in viral infections?
J. Virol.
72:4547-4551[Free Full Text].
|
| 28.
|
Robertson, M. D., and G. E. Wilcox.
1986.
Avian reovirus.
Vet. Bull.
56:726-733.
|
| 29.
|
Shapouri, M. R. S.,
M. Arella, and A. Silim.
1996.
Evidence for the multimeric nature and cell binding ability of avian reovirus 3 protein.
J. Gen. Virol.
77:1203-1210[Abstract/Free Full Text].
|
| 30.
|
Shmulevitz, M., and R. Duncan.
2000.
A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses.
EMBO J.
19:902-912[CrossRef][Medline].
|
| 31.
|
Sick, C.,
K. Schneider,
P. Staeheli, and K. C. Weining.
2000.
Novel chicken CXC and CC chemokines.
Cytokine
12:181-186[CrossRef][Medline].
|
| 32.
|
Sturzenbecker, L. J.,
M. L. Nibert,
D. Furlong, and B. N. Fields.
1987.
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle.
J. Virol.
61:2351-2361[Abstract/Free Full Text].
|
| 33.
|
Sung, Y. J.,
J. H. Hotchkiss,
R. E. Austic, and R. R. Dietert.
1991.
L-Arginine-dependent production of a reactive nitrogen intermediate by macrophages of a uricotelic species.
J. Leukoc. Biol.
50:49-56[Abstract].
|
| 34.
|
Tang, K. N.,
O. J. Fletcher, and P. Villegas.
1987.
The effect on newborn chicks of oral inoculation of reovirus isolated from chickens with tenosynovitis.
Avian Dis.
31:584-590[CrossRef][Medline].
|
| 35.
|
Tenney, D. J., and P. S. Morahan.
1991.
Differentiation of the U937 macrophage cell line removes an early block of HSV-1 infection.
Viral Immunol.
4:91-102[Medline].
|
| 36.
|
Tosteson, M. T.,
M. L. Nibert, and B. N. Fields.
1993.
Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses.
Proc. Natl. Acad. Sci. USA
90:10549-10552[Abstract/Free Full Text].
|
| 37.
|
Varela, R., and J. Benavente.
1994.
Protein coding assignment of avian reovirus strain S1133.
J. Virol.
68:6775-6777[Abstract/Free Full Text].
|
| 38.
|
von Bulow, V., and A. Klasen.
1983.
Effects of avian reoviruses on cultured chicken bone-marrow-derived macrophages.
Avian Pathol.
12:179-198.
|
| 39.
|
Weining, K. C.,
C. Sick,
B. Kaspers, and P. Staeheli.
1998.
A chicken homolog of mammalian interleukin-1 beta: cDNA cloning and purification of active recombinant protein.
Eur. J. Biochem.
258:994-1000[Medline].
|
| 40.
|
Zhang, S.,
H. S. Lillehoj, and M. D. Ruff.
1995.
Chicken tumor necrosis-like factor. I. In vitro production by macrophages stimulated with Eimeria tenella of bacterial lipopolysaccharide.
Poult. Sci.
74:1304-1310[Medline].
|
Journal of Virology, June 2001, p. 5027-5035, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5027-5035.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.